Answers are grounded in this paper and cite their sources.
Cross-sectional surveys reveal healthcare providers' views on migraine prevention and rimegepant treatment.
To understand short-term prevention (STP) of migraine from the perspective of healthcare providers (HCPs) and rimegepant patient STP users.
No takes yet. Share an insight, caveat, or question.
Monteith et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: